WebAug 8, 2024 · In 2016, Steve co-founded Fount Therapeutics, a sustainable drug discovery enterprise which gave rise to Kinnate Biopharma in 2024, a small molecule precision oncology company. WebAug 27, 2024 · Fount Therapeutics secured $22 million in Series A financing from Foresite Capital and Eshelman Ventures back in April 2024 to eventually develop Kinnate. Today, the company is focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat cancers. Kinnate develops targeted therapies with its expertise in ...
Stephen Kaldor, Ph.D. Board Member - Crinetics
WebFount Therapeutics, LLC * 1 Principals See who the company's key decision makers are 1 Contacts Reach the right people with access to detailed contact information. 9 See similar companies for insight and prospecting. Start Your Free Trial WebFount Bio is a life science company developing a pipeline of innovative products for medical and beauty applications that combine proprietary innovations in biorthogonal chemistry … doctor who dalek cult of skaro
Fount Therapeutics, LLC is a sustainable drug discovery enterprise …
WebFeb 16, 2024 · BEDFORD, Mass., and SHANGHAI, China, February 2, 2024 – Frontera Therapeutics, a global clinical-stage biotechnology company that seeks to develop … WebJun 22, 2024 · He also serves as Chief Executive Officer and a director of Fount Therapeutics, LLC, and as a strategic advisor for Fronthera US Pharmaceuticals LLC, both biotechnology companies. Dr. Kaldor … WebAug 3, 2024 · Clinical case. A 32-year-old woman of South Asian descent presented with persistent dry cough and decreased exercise tolerance (Fig. 1a).Computed tomography (CT) scan of the chest revealed ... extra short wide leg trousers